ArticleCancer immunology, immunotherapy : CII2021
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer.
Kristina Witt et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this paperpooled itcites it